Unlocking the Power of the Genome
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
Illumina | Sequencing and array solutions to fuel genomic discoveries
Entity | Type | Tweets | Articles | |
---|---|---|---|---|
Camena Bioscience biotech, deeptech | Other 10 Oct 2024 | | ||
GenomiqueENS it services, Research Services | Other 22 Oct 2024 | | ||
NewWave Events Events Services | Other 4 Oct 2024 | | ||
Institut de la Mère et de l'Enfant healthtech | Other 13 Sep 2024 | | ||
Citizens of the Sea healthtech | Other 12 Sep 2024 | | ||
Pleo fintech, Financial Services | Other 12 Sep 2024 | | ||
BioFortis, a Q2 Solutions Company biotech, it services, deeptech, Software Development | Other 16 Sep 2024 | | ||
Platomics deeptech, IT Services and IT Consulting | Other 31 Jul 2024 | | ||
ICGEB biotech, deeptech, Biotechnology Research | Other 11 Sep 2024 | | ||
CEOE - CAMPUS Higher Education, edtech | Other 3 Aug 2024 | |